| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,478 |
10,906 |
$575K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,779 |
3,290 |
$131K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,088 |
1,859 |
$97K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,758 |
1,555 |
$54K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
558 |
501 |
$41K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,489 |
2,300 |
$38K |
| 59430 |
|
216 |
190 |
$32K |
| 0500F |
|
271 |
271 |
$28K |
| 87428 |
|
334 |
292 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
613 |
535 |
$18K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
417 |
377 |
$13K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
102 |
90 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
252 |
221 |
$5K |
| 73610 |
|
204 |
197 |
$5K |
| 73630 |
|
240 |
235 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
220 |
203 |
$3K |
| 73130 |
|
176 |
173 |
$3K |
| 12001 |
|
45 |
39 |
$3K |
| 81002 |
|
1,145 |
1,018 |
$3K |
| 87807 |
|
295 |
196 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
40 |
31 |
$3K |
| 81025 |
|
517 |
423 |
$3K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
169 |
157 |
$2K |
| 73564 |
|
97 |
92 |
$2K |
| 90715 |
|
60 |
47 |
$2K |
| 73110 |
|
82 |
79 |
$2K |
| 69209 |
|
154 |
129 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
17 |
16 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
12 |
$934.18 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
89 |
66 |
$882.90 |
| 73140 |
|
47 |
46 |
$819.11 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
12 |
$667.03 |
| 73030 |
|
29 |
29 |
$599.40 |
| 73080 |
|
28 |
27 |
$496.25 |
| 99421 |
|
30 |
27 |
$395.70 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
18 |
15 |
$261.00 |
| 73090 |
|
14 |
13 |
$221.21 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
152 |
118 |
$195.36 |
| 81003 |
|
92 |
83 |
$192.77 |
| 82962 |
|
72 |
66 |
$140.89 |
| 86308 |
|
19 |
17 |
$91.20 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
54 |
40 |
$63.11 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
54 |
36 |
$59.05 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
18 |
15 |
$1.96 |